The two SNPs have relatively low MAF (0.14 for NAV3 rs696468 and 0.06 for UNC5C rs72659964), limiting the genotype stratification analysis for AD neuropathology (n = 78) which results in a wide 95% CI. This evidence concerns the gene NAV3 and Alzheimer disease.